Expanded‐access use of elamipretide in a patient with membrane protein‐associated neurodegeneration.

Autor: Patino, Jorge, Clearman, Anna Haertling, Miller, Lindsey, Koenig, Mary Kay
Předmět:
Zdroj: Clinical Case Reports; Jul2024, Vol. 12 Issue 7, p1-5, 5p
Abstrakt: Key Clinical Message: This case report presents a progressively declining 17‐year‐old patient with membrane protein‐associated neurodegeneration who demonstrated symptomatic improvements in her dysarthria, dysphagia, and gait, and objective improvements in her 6‐minute walk test and 5 times sit‐to‐stand test during elamipretide treatment. [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index
Nepřihlášeným uživatelům se plný text nezobrazuje